These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1163663)

  • 41. [Effect, in obese subjects, of the inhibition of beta-adrenergic receptors on the changes of glycemia, serum free fatty acids and glycerol, produced by glucagon].
    Milcou SM; Radian N; Dinulescou E; Dragomirescou M; Mitrache L; Isaia M
    Rev Fr Endocrinol Clin; 1970; 11(4):303-10. PubMed ID: 4397330
    [No Abstract]   [Full Text] [Related]  

  • 42. Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
    Franz IW; Lohmann FW; Koch G; Quabbe HJ
    Int J Sports Med; 1983 Feb; 4(1):14-20. PubMed ID: 6132891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenergic receptor control mechanism for growth hormone secretion.
    Blackard WG; Heidingsfelder SA
    J Clin Invest; 1968 Jun; 47(6):1407-14. PubMed ID: 5653218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered sympathetic control of nutrient mobilization during physical exercise after lesions in the VMH.
    Balkan B; Strubbe JH; Bruggink JE; Steffens AB
    Am J Physiol; 1991 Feb; 260(2 Pt 2):R368-72. PubMed ID: 1996724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
    Wasserman DH; Lickley HL; Vranic M
    J Appl Physiol (1985); 1985 Oct; 59(4):1282-9. PubMed ID: 2865246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the interaction between growth hormone and dihydroergotamine in adipose cells. I. The lipolytic effect of dihydroergotamine.
    Hotta N; Sirek OV; Sirek A
    Horm Metab Res; 1971 May; 3(3):161-6. PubMed ID: 4399382
    [No Abstract]   [Full Text] [Related]  

  • 47. An involvement of alpha-adrenergic stimulation in exercise-induced hypoglycemia.
    Yajima M; Hosokawa T; Ui M
    Eur J Pharmacol; 1977 Mar; 42(1):1-9. PubMed ID: 191260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of catecholamines on in vitro release of free fatty acids in rats adapted to exercise at various temperatures.
    Górski J; Kordecki R; Kiczka K
    Acta Physiol Pol; 1973; 24(2):357-60. PubMed ID: 4711436
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute adaptation in adrenergic control of lipolysis during physical exercise in humans.
    Wahrenberg H; Engfeldt P; Bolinder J; Arner P
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E383-90. PubMed ID: 2821823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
    Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M
    FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diminished hormonal responses to exercise in trained rats.
    Galbo H; Richter EA; Holst JJ; Christensen NJ
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Dec; 43(6):953-8. PubMed ID: 606699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
    Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
    Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
    Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adrenodemedullation does not impair the beneficial effect of physical training in streptozotocin-diabetic rats.
    Jean C; Tancrede G; Rousseau-Migneron S; Nadeau A
    Metabolism; 1992 Apr; 41(4):370-6. PubMed ID: 1556943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Metabolic and hormonal peculiarities of obesity].
    Ratzmann KP
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(6):265-76. PubMed ID: 4373223
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of adrenaline on plasma levels of fatty acid in adrenalectomized rats. Possible role of adrenergic receptors].
    Baïsset A; Berlan M; Montastruc P
    C R Acad Hebd Seances Acad Sci D; 1975 Jan; 280(1):97-100. PubMed ID: 806381
    [No Abstract]   [Full Text] [Related]  

  • 57. Adrenergic system and carbohydrate metabolism. Effects of beta-receptor blockade on insulin secretion and peripheral insulin sensitivity in normoglycaemic patients.
    Ferrara LA; Capaldo B; Rivellese A; Genovese S; Iovine C; Mastranzo P; Cirillo F; Mancini M
    Eur J Clin Pharmacol; 1987; 33(3):273-7. PubMed ID: 2891537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substrate mobilization during prolonged exercise in 6-hydroxydopamine treated rats.
    Sembrowich WL; Ianuzzo CD; Saubert CW; Shepherd RE; Gollnick PD
    Pflugers Arch; 1974 May; 349(1):57-62. PubMed ID: 4858038
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma epinephrine in chronically adrenodemedullated rats: lack of response to acute or chronic exercise.
    Jean C; Tancrède G; Rousseau-Migneron S; Nadeau A
    Can J Physiol Pharmacol; 1991 Aug; 69(8):1217-21. PubMed ID: 1782604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in plasma free fatty acids after the administration of several hormones related to the pituitary-adrenocortical and the sympathetico-medullary system].
    Fujii K
    Nihon Naibunpi Gakkai Zasshi; 1972 Aug; 48(5):300-23. PubMed ID: 4342861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.